Clinicopathological Study and Management of Primary Malignant Scapular Tumors; 10 Years National Cancer Institute Experience
Abdelrahman, I., El-Sherbiny, M., Fayek, I., Shaker, I., Taher, M. (2023). Clinicopathological Study and Management of Primary Malignant Scapular Tumors; 10 Years National Cancer Institute Experience. EKB Journal Management System, 91(1), 3807-3812. doi: 10.21608/ejhm.2023.293456
Ibrahim Abdelrahman; Magdy El-Sherbiny; Ihab Fayek; Ibrahim Shaker; Mohammad Taher. "Clinicopathological Study and Management of Primary Malignant Scapular Tumors; 10 Years National Cancer Institute Experience". EKB Journal Management System, 91, 1, 2023, 3807-3812. doi: 10.21608/ejhm.2023.293456
Abdelrahman, I., El-Sherbiny, M., Fayek, I., Shaker, I., Taher, M. (2023). 'Clinicopathological Study and Management of Primary Malignant Scapular Tumors; 10 Years National Cancer Institute Experience', EKB Journal Management System, 91(1), pp. 3807-3812. doi: 10.21608/ejhm.2023.293456
Abdelrahman, I., El-Sherbiny, M., Fayek, I., Shaker, I., Taher, M. Clinicopathological Study and Management of Primary Malignant Scapular Tumors; 10 Years National Cancer Institute Experience. EKB Journal Management System, 2023; 91(1): 3807-3812. doi: 10.21608/ejhm.2023.293456

Clinicopathological Study and Management of Primary Malignant Scapular Tumors; 10 Years National Cancer Institute Experience

The Egyptian Journal of Hospital Medicine
Article 7, Volume 91, Issue 1, April 2023, Page 3807-3812  XML PDF (217.31 K)
Document Type: Original Article
DOI: 10.21608/ejhm.2023.293456
View on SCiNiTO View on SCiNiTO
Authors
Ibrahim Abdelrahman; Magdy El-Sherbiny; Ihab Fayek; Ibrahim Shaker; Mohammad Taherorcid
Surgical Oncology Department, National Cancer Institute - Cairo University, Cairo, Egypt
Abstract
Introduction: Primary malignant scapular tumors are very rare. Little is written about flat bone sarcomas in the literature, and not much is known about the oncological outcome. Objective: The aim of the current work isreviewing clinicopathological features and surgical management of cases with primary malignant scapular tumors.
Patients and methods: Patients with primary malignant scapular tumours who visited the National Cancer Institute (NCI) at Cairo University, Egypt, between January 2009 and December 2019 were subjected to a retrospective descriptive analysis.
Results: The study included 25 patients with a mean age of 33.4 years old ranging from 9 to 86 years. Pathology types were chondrosarcoma in 14 patients (56%), Ewing/PNET in 7 patients (28%), osteosarcoma in 2 patients (8%), spindle cell sarcoma in 1 patient (4%), and aneurysmal bone cyst in 1 patient (4%). Twenty patients (80%) had surgery, and 5 patients (20%) had no surgical intervention for being either with a poor general condition or having metastatic disease. Overall survival at 6 months was 92% and was 88%, 75.4%, and 65.4% in the first year, 3rd year, and 5th year respectively. Disease-free survival at 6 months was 90.5%; and was 85.7%, 75.4%, and 42.7% in the first year, 3rd year, and 5th year respectively.
Conclusion: Primary malignant scapular tumors are rare. Early diagnosis is very important, as surgical excision with a wide negative margin (limb-sparing surgery) is the main line of treatment in most cases and tends to decrease the recurrence rate, otherwise, palliative treatment and forequarter amputation may be indicated.
 
Keywords
Scapular tumors; Scapulectomy; Limb-sparing surgery; Retrospective descriptive analysis; National Cancer Institute; Cairo University
Statistics
Article View: 212
PDF Download: 348